Manipulate the default connectome provided with TVB to see how structural lesions effect brain dynamics. In this hands-on session you will insert lesions into the connectome within the TVB graphical user interface (GUI). Afterwards, the modified connectome will be used for simulations and the resulting activity will be analysed using functional connectivity.

This talk describes the NIH-funded SPARC Data Structure, and how this project navigates ontology development while keeping in mind the FAIR science principles. 

This lecture covers structured data, databases, federating neuroscience-relevant databases, and ontologies. 

This lecture covers FAIR atlases, including their background and construction, as well as how they can be created in line with the FAIR principles.

This lesson provides an introduction the International Neuroinformatics Coordinating Facility (INCF), its mission towards FAIR neuroscience, and future directions. 

In this talk, you will learn about the standardization schema for data formats among two of the US BRAIN Initiative networks: the Cell Census Network (BICCN) and the Cell Atlas Network (BICAN). 

This talk discusses what are usually considered successful outcomes of scientific research consortia, and how those outcomes can be translated into lasting impacts. 

This final lesson of the course consists of the panel discussion for Streamlining Cross-Platform Data Integration session during the first day of INCF's Neuroinformatics Assembly 2023. 

This brief talk describes the challenge of global data sharing and governance, as well as efforts of the the Brain Research International Data Governance & Exchange (BRIDGE) to develop ready-made workflows to share data globally. 

This lesson is the first part of a three-part series on the development of neuroinformatic infrastructure to ensure compliance with European data privacy standards and laws. 

This brief video gives an introduction to the eighth session of INCF's Neuroinformatics Assembly 2023, focusing on FAIR data and the role of academic journals. 

This brief talk outlines the obstacles and opportunities involved in striving for more open and reproducible publishing, highlighting the need for investment in the technical and governance sectors of FAIR data and software. 

This talk gives an overview of the complicated nature of sharing of neuroscientific data in an environment of numerous and often conflicting legal systems around the world. 

This lecture covers a wide range of aspects regarding neuroinformatics and data governance, describing both their historical developments and current trajectories. Particular tools, platforms, and standards to make your research more FAIR are also discussed.

This lecture covers the needs and challenges involved in creating a FAIR ecosystem for neuroimaging research.

This lecture covers multiple aspects of FAIR neuroscience data: what makes it unique, the challenges to making it FAIR, the importance of overcoming these challenges, and how data governance comes into play.

In this interdisciplinary panel discussion, panelists explored and discussed the technical, ethical, and legal dimensions of brain data governance and neurorights.

Open Brain Consent is an international initiative aiming to address the challenge of creating participant consent language that will promote the open sharing of data, protect participant privacy, and conform to legal norms and institutional review boards.

Open Brain Consent addresses the aforementioned difficulties in neuroscience research with human participants by collecting:

• widely acceptable consent forms (with various translations) allowing deposition of anonymized data to public data archives
• collection of tools/pipelines to help anonymization of neuroimaging data making it ready for sharing

This brief talk goes into work being done at The Alan Turing Institute to solve real-world challenges and democratize computer vision methods to support interdisciplinary and international researchers. 

The state of the field regarding the diagnosis and treatment of major depressive disorder (MDD) is discussed. Current challenges and opportunities facing the research and clinical communities are outlined, including appropriate quantitative and qualitative analyses of the heterogeneity of biological, social, and psychiatric factors which may contribute to MDD.